When Elliot Williams and Al Williams compare their notes on the week in Hackaday, you know you’ll get at least one or two bad puns. How bad? Tune in and find out. This week, Tom Nardi visits ...
Merck & Co's efforts to diversify its cancer pipeline beyond immunotherapy blockbuster Keytruda have taken a big step forward with a wide-ranging alliance with China's Kelun-Biotech that spans seven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results